| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.15 | 0.4 |